Authors: Fox, SH Henry, B Hill, MP Peggs, D Crossman, AR Brotchie, JM

Citation: Sh. Fox et al., Neural mechanisms underlying peak-dose dyskinesia induced by levodopa and apomorphine are distinct: Evidence from the effects of the alpha(2) adrenoceptor antagonist idazoxan, MOVEMENT D, 16(4), 2001, pp. 642-650

Authors: Nash, JE Fox, SH Henry, B Hill, MP Peggs, D McGuire, S Maneuf, Y Hille, C Brotchie, JM Crossman, AR

Citation: Je. Nash et al., Antiparkinsonian actions of ifenprodil in the MPTP-lesioned marmoset modelof Parkinson's disease, EXP NEUROL, 165(1), 2000, pp. 136-142

Authors: Henry, B Fox, SH Peggs, D Crossman, AR Brotchie, JM

Citation: B. Henry et al., The alpha(2)-adrenergic receptor antagonist idazoxan reduces dyskinesia and enhances anti-parkinsonian actions of L-dopa in the MPTP-lesioned primatemodel of parkinson's disease, MOVEMENT D, 14(5), 1999, pp. 744-753